Latest / "Isn't That Interesting?!": Breast Cancer Survivor Stories + Remarkable Research / Season 2 / Episode 11: Dr. Victoria Mango
Transcript
- 0:01It's the size of a cell phone, totally wireless, and claims to
- 0:04detect breast abnormalities in seconds.
- 0:08Now, isn't that interesting? But can it really do the job,
- 0:11especially in areas where there are no mammograms, ultrasounds,
- 0:15or even doctors? A Sloan Kettering radiologist
- 0:18shares her earlier.org backed research with Martha Kaley, our
- 0:22founder and executive director. Hi everybody.
- 0:27This is Doctor Victoria Mango and she is at Sloan Kettering
- 0:31Memorial and we are so excited to have her here and she's going
- 0:37to talk about her work and from the grant that we awarded, and
- 0:42then she's going to tell you how that led to some other work too.
- 0:47So, Doctor Mango, I'm going to let you go ahead and just begin
- 0:51your information about your work.
- 0:53Sure. Well, thank you so much for
- 0:55having me and thank you so much for your support of this work.
- 0:59It really was a pivotal award for me to get started on the
- 1:04this line of research. And so for some background, I
- 1:08specialize in diagnostic radiology and I focus completely
- 1:13on breast cancer. So my clinical practice at
- 1:16Memorial Sloan Kettering is really focused on screening
- 1:20women finding and diagnosing cancer as early as we can.
- 1:25The other part of my role at Sloan Kettering is I'm assistant
- 1:29director of our global Cancer Research and training
- 1:33initiatives. And so that allows me to take
- 1:36what we learn at Memorial Sloan Kettering and see how can we
- 1:39help women all all over the world.
- 1:41So we work in a lot of low resource communities, many
- 1:44countries in sub-Saharan Africa to see how can we apply what we
- 1:49know in a low resource context to help women globally.
- 1:54And so the the grant from earlier.org was really pivotal
- 1:59to start one of our studies looking at a new technology.
- 2:03So this is something called the I Breast exam.
- 2:06So you have your iPhone, this is the I Breast exam and it's
- 2:10really meant to be used in low resource settings.
- 2:14So some of the countries where we work, there might only be 1
- 2:18mammography machine for 500,000 women.
- 2:22So unlike in New York City where I'm very spoiled and I can
- 2:26promote, I want all women to come in for their annual
- 2:28mammograms that that's just not feasible in in some areas of the
- 2:32world for a variety of reasons. So what this eye breast exam
- 2:37does is it's a highly portable device.
- 2:41It's very durable. It can be used in very, you
- 2:44know, high heat situations. It can be dropped without an
- 2:47issue, and it can be used with a very minimal training and it's
- 2:51not painful. It's something that you just
- 2:53place on the breast and it essentially electronically
- 2:57palpates the breast and it tells us if a certain area is a little
- 3:01bit more firm than another and may warrant additional
- 3:05evaluation. And so this is somewhat
- 3:07analogous to a clinical breast exam where you might have a
- 3:11nurse or a doctor examine the breast with their hands to see
- 3:15if they feel a lump. And so when we think about low
- 3:19resource areas, those areas with very few imaging machines and
- 3:23imaging experts, there's also not a lot of physicians who are
- 3:27trained in that clinical breast exam.
- 3:30So a device like this could be very powerful in the hands of a
- 3:35community health worker. It can be brought to rural
- 3:38environments and provide an easy way to screen women and evaluate
- 3:43the breast. The thing about new technology
- 3:45is, is we need a way to evaluate it very rigorously and compare
- 3:49it to standard of care. So I was so honored to be a
- 3:53recipient of this this grant, which allowed us to look at it
- 3:57in our Harlem center, our Ralph Lauren Center, through Memorial
- 4:00Sloan Kettering, and really compare it to two things.
- 4:04So we had three hundred women and they all underwent the same
- 4:08three tests. So they had this eye breast exam
- 4:12and then we compared it to a clinical breast exam that was
- 4:15done by a very experienced nursing staff at Ralph Lauren.
- 4:20And then we had a high quality mammogram that was done.
- 4:25So 300 women had these three tests on the same day and we
- 4:29could see how well the the device did.
- 4:33And so this was a small pilot and out of 300 women, there were
- 4:37three cancers that were diagnosed.
- 4:40And of those 3 cancers, only one of them was found with the
- 4:45clinical breast exam and the eye breast exam, which is not
- 4:49surprising, right? Mammography is going to find
- 4:51cancers before they are palpable or can be felt by the hand or or
- 4:56by this device. And so with this initial small
- 4:59cohort, it showed us that it performed very similarly to the
- 5:03trained clinical breast exam. So that's an important finding
- 5:06in and of itself that this device might be able to take
- 5:10that trained clinical breast exam and put in the hands of
- 5:13someone with minimal training replicate that clinical breast
- 5:17exam. But it also showed us that
- 5:19mammography still found two cancers that weren't detected by
- 5:23Palpation. And so this laid some crucial
- 5:27groundwork that allowed us to obtain additional funding to
- 5:31actually pilot this in Nigeria. Our partners there LED a very
- 5:36robust study of about 425 women, again looking at the eye breast
- 5:41exam and comparing it to a surgeon's clinical breast exam.
- 5:45And so with this group, we had 15 cancers and the eye breast
- 5:49exam and the clinical breast exam both found 13 out of those
- 5:5415. So results were somewhat similar
- 5:57in that we're finding cancers using this device, but not quite
- 6:02as many as we find with our standard imaging tools.
- 6:06One of the issues we've run into is a low specificity.
- 6:11So in Nigeria, when we put this in the hand of junior nurses who
- 6:15just finished nursing school in Nigeria, we had a lot of false
- 6:19positives and that's something we have to think about very
- 6:23critically. In a low resource setting, we
- 6:26need to have negative exams that we can be confident in.
- 6:30So too many false positives could overwhelm our system.
- 6:34If we only have one radiologist and one mammogram machine, we
- 6:38can't bring out a tool to scan 1000 women and have 500 of them
- 6:43have false positive exams. So we're learning along the way.
- 6:48The device isn't quite ready for prime time, but it's, it's
- 6:51through these rigorous research evaluations and, and support
- 6:56from earlier.org that really gives this vital pilot data that
- 7:00can help us to, to launch this globally, understand it in
- 7:04different contexts and really think about how we might use
- 7:08this to help women that don't have access to, you know,
- 7:12mammography, ultrasound, the, the things that we have at, at
- 7:15Sloan Kettering in New York. So would would the radiologist
- 7:20Is there how? How would these exams be read?
- 7:26So what's really nice about the eye breast exam is it doesn't
- 7:30require any interpretation. I, I could teach you to do it in
- 7:33about 15 minutes and basically it's either green or red.
- 7:38So you'll see a map of the breast and maybe in in one
- 7:41little area, there's a red spot and that doesn't tell you
- 7:45whether it's cancer or not, but it flags this as this is a woman
- 7:49that should, you know, make the trip to get the mammogram, get
- 7:52the ultrasound because there there may be an area of concern.
- 7:56And I think that's one of the desirable aspects of a tool like
- 8:00this is it can be used with minimal training.
- 8:02You don't need a lot of expertise to interpret it the
- 8:04way you would, you know, a mammogram or an ultrasound.
- 8:08So would calcifications like in logular breast cancer, would
- 8:12calcifications be? Would that precipitate the red
- 8:17dot as opposed to the green dot? That's an excellent point.
- 8:22So that was one thing that we did see in our research.
- 8:26So often the calcifications associated with breast cancer
- 8:30are so tiny, you can picture almost like powdered sugar or
- 8:34little dots of sand. And so that can be a sign of
- 8:38like a very early breast cancer, like a ductal carcinoma in site
- 8:422. And that is often not palpable.
- 8:45And so that's actually the, the study that that you all funded
- 8:49showed that the, the cancers that were missed it one of them
- 8:52was purely calcification. So it's something that I would
- 8:56expect to only be seen with a mammogram and and not felt on
- 9:00exam like clinician or with the eye breast exam.
- 9:05Right. How do you see the time frame
- 9:09for this? What do you see?
- 9:11What is your hope for the time frame of of being able to put
- 9:14this in utilization? So our next steps are again
- 9:20focused on West Africa, really lower resource settings and
- 9:24using it in the hands of community health workers.
- 9:28So far, the environments where we've tested it, you know, 1 is
- 9:31at Memorial Sloan Kettering, the second at a very large academic
- 9:35center in Nigeria. And I think that the next step
- 9:38is to see how does it perform in the community setting, in the
- 9:42rural setting, in a controlled study where again, we can
- 9:46compare it to current standard of care to see how it does.
- 9:50So I think, you know, we need some tweaking with the device to
- 9:54improve that specificity. We need to have an understanding
- 9:58of what it misses. So in the community where we
- 10:01work in Nigeria, for example, the average breast tumor size is
- 10:0510 1/2 centimeters on presentation, so much much
- 10:10larger. So even if we can downstage to
- 10:12detecting these at at 2cm, at 3 centimeters, that could be a a
- 10:18difference between being diagnosed at stage 4 or being
- 10:22diagnosed at, at stage 2, still highly treatable.
- 10:25So we can still have a large impact even if we're not
- 10:29catching those, you know, super tiny very early cancers, but
- 10:32just diagnosing them earlier when they can be more treatable.
- 10:37Absolutely. That is fascinating information
- 10:42and work. I What do you what leads you all
- 10:46to think about causes of the false positives?
- 10:52So our So what part of this work was getting a lot of feedback
- 10:55from the people that were using it.
- 10:58Some of the comments had to do, for example, if a woman was very
- 11:00thin, sometimes the device seems to detect a rib actually through
- 11:05the breast, so or the sternum. So it's actually feeling a
- 11:08firmer area, but it's actually the bone underneath.
- 11:12And so we've kind of worked at some troubleshooting with
- 11:15repositioning women and kind of correlating, you know, with,
- 11:18with structures underneath someone just some just have
- 11:21denser firm tissue in some areas.
- 11:24And and that can be very tricky on a clinical breast exam as
- 11:27well to know that this is normal tissue or not.
- 11:31And I think a lot of patients that that's very challenging
- 11:34when you do your own self breast exam to know whether or not this
- 11:38is something to worry about or not.
- 11:40And so I think a device like this faces similar challenges.
- 11:45And I think it's interesting that the dense breast tissue
- 11:48that and I and I, I have learned how, how consequential that is.
- 11:55Did you find that that was standard that you could the
- 12:01number of women that were tested, was that a larger
- 12:06percentage of them with a dense breast tissue or did did you
- 12:10define that? So our patient population was
- 12:15not selected based on breast density.
- 12:17And so we had kind of what we would expect for a standard
- 12:21population, which is about half of the women have dense breast
- 12:24tissue. But it's something we take very
- 12:27seriously. We know that it dense tissue is
- 12:30not abnormal if it's normal anatomy, but it does increase a
- 12:34woman's risk for breast cancer and it also decreases the
- 12:39sensitivity of the mammogram. You should still get a mammogram
- 12:43with dense tissue, but we know that the benefits of
- 12:46supplemental screening. So for example, getting an
- 12:49ultrasound or if you're higher risk getting an MRI there.
- 12:52There are definitely cancers that we won't see on mammography
- 12:56that we can find with the addition of supplemental
- 12:59imaging. So what's your hope for what AI
- 13:03can, how it can work and and grow?
- 13:06So tell me about that. I think that's exciting.
- 13:09So we have a couple AI studies going on in, in different areas
- 13:13of the world and when we're starting to use it at Memorial
- 13:16Sloan Kettering with both mammography and ultrasound.
- 13:20And I as a radiologist, really appreciate, AII appreciate that
- 13:24there's another look at this image.
- 13:27So the way it's used in, in my practice is I, I read the
- 13:31mammogram the way I normally would and then before I make a
- 13:34final conclusion, an AI report pops up and it's got circles on
- 13:39different areas I should look at more closely.
- 13:41And I go back and I look at them very carefully.
- 13:44It does have what are a lot of false positives.
- 13:47It doesn't necessarily know what the prior mammograms looked
- 13:50like, like. So it still requires the
- 13:52radiologist to say, you know what, I get why you're circling
- 13:55that, but that's been stable for 10 years.
- 13:57So we're, we're not going to about it.
- 13:59So it requires that, you know, constant kind of human check,
- 14:02but it's a supplemental tool that can really help us find
- 14:06more cancer. So we're, we're using that with
- 14:08both mammography and ultrasound and we currently are working on
- 14:14an ultrasound AI project in Nigeria as well.
- 14:18So again, a way to supplement where there might be people with
- 14:21less training or out in the community doing breast
- 14:23ultrasound. How can AI help them
- 14:26appropriately interpret these images?
- 14:29And it's amazing to me that a person can be just trying to, to
- 14:36use this instrumentation just, you know, not everybody.
- 14:40That was one of the thoughts I had as I was learning about
- 14:45this. And I was thinking, well, does
- 14:47it have to be somebody who does this only a nurse or or whatever
- 14:54if, if that's their work, because then to be familiar with
- 14:58it. But obviously the
- 15:00instrumentation just does all of that interpretation correct.
- 15:05Yeah, for the eye breast exam, it's really meant to be
- 15:10accessible so it can be used by someone with very limited
- 15:14training. So you know, we're we're hopeful
- 15:16that with some improvement this could really have an impact in
- 15:19in low resource environments. But again, and in all of our
- 15:23studies, it breast imaging, traditional imaging, mammography
- 15:27and ultrasound has outperformed the device because I know a lot
- 15:30of women they, well not a fair number of women don't enjoy
- 15:34getting a mammogram, which is understandable with the
- 15:36compression and breast sensitivity.
- 15:39Just. So I just want to make clear
- 15:40that it's not performing at the level of our current imaging
- 15:43tools. And so it's not a replacement
- 15:45for that, but something that could supplement and certainly
- 15:48help in areas where mammography may not be available.
- 15:51And that's really what we're working for is to put the
- 15:56instruments into into use, but it has to be supervised or, or
- 16:03understood by people who are experts in that.
- 16:07So I think that that's really helpful.
- 16:10Well, your, your outlook for the time frame and you're, you're
- 16:15doing another, you're doing another research project, right,
- 16:19in a larger scale, correct, right.
- 16:22Well, is there anything you want, anything else you want to
- 16:24discuss? I appreciate so much your
- 16:28sharing your time with us and your expertise.
- 16:31And of course, I'm in all of this instrumentation that we
- 16:36have and how it's being utilized.
- 16:40So is there anything else you would like to say?
- 16:43I just want to say a huge thank you to earlier.org, your
- 16:46organization and your donors. This type of support can be just
- 16:51so pivotal and foundational to us getting started with these
- 16:56new technologies. And really to provide an
- 16:59independent evaluation, we need studies where the company
- 17:02themselves are not funding the study, I think is, you know,
- 17:05critical when we look at this data.
- 17:07And so really through your support got us started on this
- 17:11row that has led to larger and more global efforts.
- 17:16And so I'm sincerely appreciative to, to you all and
- 17:19to our our research team who's been essential for for getting
- 17:23this work done. So thank you so very much.
- 17:25Yeah. Well, you're very welcome.
- 17:27And it makes me very happy to think that that this work can be
- 17:33translated globally. That has been my hope for for
- 17:36finding a better method for earlier detection.
- 17:40So thank you so much and thank you again for for joining us.
- 17:45Thank you so much. Take care.
- 17:46OK, you too. Bye bye.
- 17:49This episode of Isn't That Interesting was made possible
- 17:52thanks to volunteers and donors just like you.
- 17:54It was hosted by Martha Kaley, founderofearlier.org and edited
- 17:59by Liam Mcburney. I'm Valerie Amsterdam, reminding
- 18:02you that for the last 30 years, this is North Carolina based
- 18:06organization has helped fund groundbreaking research all over
- 18:09the world, from molecular imaging to a sensitive blood
- 18:13test for breast cancer. Plain and simple, earlier
- 18:16detection saves lives. And you can help host a
- 18:19fundraising event. Make a donation for Volunteer
- 18:22Your Time. You can find us not only on the
- 18:24web but on Facebook and Instagram too.
- 18:27Let's change the picture of breast cancer together.